Daily briefing: First in-womb treatment for motor-neuron condition is a success
Briefly

A groundbreaking treatment for a rare motor-neuron condition has been developed in utero, showing promising results in a toddler. This therapy utilizes the gene-targeting drug Risdiplam to enhance the expression of the SMN2 gene, crucial for motor neuron health. Additionally, the article discusses the implications of the U.S. withdrawal from the WHO, indicating potential short-term challenges alongside possible benefits in funding balance. Furthermore, advances in AI are highlighted with the introduction of WHAM, a generative engine creating dynamic video game environments, and Microsoft’s progress in quantum computing with topological qubits.
A two-and-a-half-year-old girl shows no signs of a rare genetic disorder after becoming the first person to be treated for a motor-neuron condition while in the womb.
The United States's withdrawal from the WHO will pose challenges for disease monitoring, but it could lead to healthier funding dynamics among member countries.
The newly developed generative AI engine, WHAM, can create immersive video game worlds that respond dynamically to player actions based on extensive training data.
Microsoft's achievement of topological qubits marks a significant milestone in quantum computing, with potential implications for future technology development.
Read at Nature
[
|
]